Log in

Relevant bibliographies by topics / Therapeutic risk

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Therapeutic risk'

Author: Grafiati

Published: 4 June 2021

Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Therapeutic risk.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Therapeutic risk"

1

BORGES, LAUREN M., SARRA NAZEM, BRIDGET B. MATARAZZO, SEAN M. BARNES, and HAL S. WORTZEL. "Therapeutic Risk Management." Journal of Psychiatric Practice 25, no. 1 (2019): 46–53. http://dx.doi.org/10.1097/pra.0000000000000358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

NAZEM, SARRA, CHRISTINE PAO, and HAL WORTZEL. "Therapeutic Risk Management." Journal of Psychiatric Practice 26, no. 3 (2020): 235–40. http://dx.doi.org/10.1097/pra.0000000000000465.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Corre, Jill, and Hervé Avet-Loiseau. "Risk-Based Therapeutic Strategies." Cancer Journal 25, no. 1 (2019): 54–58. http://dx.doi.org/10.1097/ppo.0000000000000352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Felton, Anne, Nicola Wright, and Gemma Stacey. "Therapeutic risk-taking: A justifiable choice." BJPsych Advances 23, no. 2 (2017): 81–88. http://dx.doi.org/10.1192/apt.bp.115.015701.

Full text

Abstract:

SummaryTaking risks is a fundamental part of the human experience that supports personal growth. Therapeutic risk-taking enables patients to make decisions about their level of safety and to pursue goals. Promoting therapeutic risk-taking can be complex. Professionals can experience tension striving for a balance between the interests of the individual and societal pressures to control risk. This article examines therapeutic risk-taking, recognising the challenges to supporting it in practice and debating how they may be overcome.Learning Objectives• Be able to explain what therapeutic risk-ta

APA, Harvard, Vancouver, ISO, and other styles

5

Mol, Peter. "Therapeutic Risk Management of Medicines." Drug Safety 37, no. 12 (2014): 1067–68. http://dx.doi.org/10.1007/s40264-014-0233-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

WORTZEL, HAL S., LAUREN M. BORGES, SEAN M. BARNES, et al. "Therapeutic Risk Management for Violence: Clinical Risk Assessment." Journal of Psychiatric Practice 26, no. 4 (2020): 313–19. http://dx.doi.org/10.1097/pra.0000000000000481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Stickley, Theodore, and Anne Felton. "Promoting recovery through therapeutic risk taking." Mental Health Practice 9, no. 8 (2006): 26–30. http://dx.doi.org/10.7748/mhp2006.05.9.8.26.c1910.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Felton, Anne. "Therapeutic risk taking: what is it?" RIVISTA SPERIMENTALE DI FRENIATRIA, no. 3 (November 2015): 89–104. http://dx.doi.org/10.3280/rsf2015-003006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hartzema, Abraham G. "Therapeutic risk management: the pharmacist's role." International Journal of Pharmacy Practice 16, no. 4 (2008): 205–10. http://dx.doi.org/10.1211/ijpp.16.4.0001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Liang, Fern Z. "Hospital Risk in Selecting Therapeutic Alternates." American Journal of Health-System Pharmacy 45, no. 5 (1988): 1052–59. http://dx.doi.org/10.1093/ajhp/45.5.1052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Therapeutic risk"

1

Machado, Diogo Alcino de Abreu Ribeiro Carvalho. "Myelodysplastic Syndromes - Therapeutic options in high-risk patients." Dissertação, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/52785.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Machado, Diogo Alcino de Abreu Ribeiro Carvalho. "Myelodysplastic Syndromes - Therapeutic options in high-risk patients." Master's thesis, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/52785.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hillert, Lena. "Hypersensitivity to electricity : symptoms, risk factors and therapeutic interventions /." Stockholm : Karolinska Univ. Press, 2001. http://diss.kib.ki.se/2001/91-7349-016-4/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Reeves, Andrew. "Assessing suicide risk in counselling : training counsellors to integrate suicide risk assessment into the therapeutic discourse." Thesis, University of Birmingham, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pyke, Chris. "Risk quantification, therapeutic morbidity and quality of life in breast cancer /." St. Lucia, Qld, 2003. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe17887.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Alachkar, Houda. "Novel Biological Insights and Therapeutic Approaches in High-Risk Acute Myeloid Leukemia." The Ohio State University, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=osu1354057251.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pershing, Rebekah L. "Outcome evaluation of a therapeutic day camp for high risk children and adolescents." Xavier University / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=xavier1386598702.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

O'Brien, Rachel Christine. "Youth harvest exploring an employment-based, service-oriented, therapeutic program for at-risk-youth /." Diss., [Missoula, Mont.] : The University of Montana, 2009. http://etd.lib.umt.edu/theses/available/etd-01192010-131511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Burgon, Hannah Louise. "Reflexive exploration of the experiences of at-risk young people participating in therapeutic horsemanship." Thesis, Cardiff University, 2011. http://orca.cf.ac.uk/54446/.

Full text

Abstract:

This thesis is part of a journey that has encompassed a lifetime love of horses. It evolved from horses being a childhood passion, and led to working with horses together with young people with various disadvantages and difficulties in a therapeutic and educational capacity. The PhD research study followed as an attempt to articulate and share some of the experiences of ‘The Yard’, the therapeutic horsemanship (TH) programme on which this thesis is based. Through a personal belief and understanding that contact with horses could be therapeutic in a number of ways I found myself in the fortunat

APA, Harvard, Vancouver, ISO, and other styles

10

Swart, Barbour Tania. "The therapeutic alliance as a component of risk management and assessment in forensic mental health." Thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/28370.

Full text

Abstract:

Background: Few forensic mental health facilities in South Africa use formal risk assessment instruments to monitor risk and recovery of forensic state patients. The study set out to examine the usefulness of the therapeutic alliance as a proxy measure of violent recidivism in a forensic state facility. The study proposed that the nature and strength of the therapeutic alliance is associated with risk of violence in a forensic population and that attachment security is a relevant factor in this relationship. Additional related factors were studied including demographic and contextual data and

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Therapeutic risk"

1

Slovic, Paul. The perception and management of therapeutic risk. Centre for Medicines Research, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hypnosis complications: Prevention and risk management. C.C. Thomas, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Smith, Howard S. Opioid risk management: Tools and tips. Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Smith, Howard S. Opioid risk management: Tools and tips. Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Smith, Howard S. Opioid risk management: Tools and tips. Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Smith, Howard S. Opioid risk management: Tools and tips. Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

G, Fine P., and Passik Steven D, eds. Opioid risk management: Tools and tips. Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Post traumatic stress disorder and dramatherapy: Treatment and risk reduction. Jessica Kingsley Publishers, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Management of lipid disorders: A basis and guide for therapeutic intervention. William & Wilkins, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Maris, Ronald W. Pillaged: Psychiatric medications and suicide risk. The University of South Carolina Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Therapeutic risk"

1

Morris, Louis A. "Physician’s Risk Disclosure." In Communicating Therapeutic Risks. Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4612-3354-1_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Simonsen, Sigmund. "Therapeutic Research." In Acceptable Risk in Biomedical Research. Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-2678-9_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Morris, Louis A. "Effects of Risk Communication." In Communicating Therapeutic Risks. Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4612-3354-1_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Morris, Louis A. "Mass Media Risk Communication." In Communicating Therapeutic Risks. Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4612-3354-1_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Devasena T. "Nanotoxicity and Risk Assessment." In Therapeutic and Diagnostic Nanomaterials. Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-0923-5_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Boffa, Michael B., Santica M. Marcovina, and Marlys L. Koschinsky. "Lipoprotein(a) as an Emerging Risk Factor for Atherothrombosis." In Therapeutic Lipidology. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Denke, Margo A. "Dietary Prescriptions to Control Dyslipidemias and Coronary Disease Risk." In Therapeutic Lipidology. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bays, Harold E. "Lowering Low-Density Lipoprotein Cholesterol Levels to Reduce Atherosclerotic Coronary Heart Disease Risk." In Therapeutic Lipidology. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Eeckhoudt, Louis. "Treatment Decisions Under Therapeutic Risks." In Risk and Medical Decision Making. Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0991-2_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Melga, P., V. Cheli, R. Giusti, G. S. Mela, and R. Prando. "Diabetic Nephropathy: Prevalence and Risk Factors." In New Therapeutic Strategies in Nephrology. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3884-4_53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Therapeutic risk"

1

Solovov, V. A., M. O. Vozdvizhenskiy, and Y. S. Matysh. "HIFU therapy for patients with high risk prostate cancer." In PROCEEDINGS FROM THE 14TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. Author(s), 2017. http://dx.doi.org/10.1063/1.4977656.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kuliha, Martin, David Školoudík, Martin Martin Roubec, et al. "Risk reduction of brain infarction during carotid endarterectomy or stenting using sonolysis - Prospective randomized study pilot data." In 12TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2012. http://dx.doi.org/10.1063/1.4769951.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Baldus, S., N. Bibinov, C. Suschek, and P. Awakowicz. "Risk assessment of a plasma device for therapeutic use in dermatology." In 2012 IEEE 39th International Conference on Plasma Sciences (ICOPS). IEEE, 2012. http://dx.doi.org/10.1109/plasma.2012.6383700.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wylie, M. P., G. B. McGuinness, and G. P. Gavin. "Therapeutic ultrasound angioplasty: The risk of arterial perforation. an in vitro study." In 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2009. http://dx.doi.org/10.1109/iembs.2009.5334036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Iadanza, E., F. Gaudio, and F. Marini. "The diagnostic-therapeutic process. Workflow analysis and risk management with IT tools." In 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2013. http://dx.doi.org/10.1109/embc.2013.6610612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Abdelfattah, Nourhan, Panneerdoss Subbarayalu, Benjamin Onyeagucha, Subapriya Rajamanickam, Hung-I. Harry Chen, and Manjeet Rao. "Abstract B01: MicroRNAs as novel therapeutic adjuvants to treat high-risk medulloblastoma." In Abstracts: AACR Special Conference: Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship; November 9-12, 2015; Fort Lauderdale, Florida. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.pedca15-b01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Moore, Kate M., Gareth J. Thomas, Stephen W. Duffy та ін. "Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer". У Abstracts: AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications - October 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1557-3125.advbc-b046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Valdora, Francesca, Florian Freier, Livia Garzia, et al. "Abstract 5050: KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hunter, David J. "Prediction of disease risk using common genetic variants." In AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development– Sep 27-30, 2010; Denver, CO. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/diag-10-pl5-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Xu, Jianfeng. "Potential clinical utilities of prostate cancer risk-associated SNPs." In AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development– Sep 27-30, 2010; Denver, CO. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/diag-10-pl5-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Therapeutic risk"

1

Worsham, Maria J., Usha Raju, and Gary Chase. Molecular Differentiation of Risk for Disease Progression: Delineating Stage-Specific Therapeutic Targets for Disease Management in Breast Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada418914.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Worsham, Maria J., Usha Raju, Gary Chase, and Mei Lu. Molecular Differentiation of Risk for Disease Progression: Delineating Stage-Specific Therapeutic Targets for Disease Management in Breast Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada432140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Li, Manyu, Jiannan Yao, and Guangyu An. The relative risk of immune-related colitis with immune checkpoint inhibitors among various therapeutic patterns: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Library, Spring. Schizophrenia & the Mental Fog. Spring Library, 2020. http://dx.doi.org/10.47496/sl.blog.18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wiley, Jenny L., Camille K. Gourdet, and Brian F. Thomas. Cannabidiol: Science, Marketing, and Legal Perspectives. RTI Press, 2020. http://dx.doi.org/10.3768/rtipress.2020.op.0065.2004.

Full text

Abstract:

Recent loosening of legal restrictions on cannabis and its chemical constituents, including phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has led to rapid proliferation and wide availability of products containing CBD. Although using pure CBD does not result in THC-like intoxication, it is not risk-free. In this review, we examine CBD from scientific, marketing, and regulatory perspectives. Specifically, we evaluate the evidence used to support statements concerning CBD’s real and putative medical effects and discuss misleading information that has been used in

APA, Harvard, Vancouver, ISO, and other styles

6

Hawkins, Brian T., and Sonia Grego. A Better, Faster Road From Biological Data to Human Health: A Systems Biology Approach for Engineered Cell Cultures. RTI Press, 2017. http://dx.doi.org/10.3768/rtipress.2017.rb.0015.1706.

Full text

Abstract:

Traditionally, the interactions of drugs and toxicants with human tissue have been investigated in a reductionist way—for example, by focusing on specific molecular targets and using single-cell-type cultures before testing compounds in whole organisms. More recently, “systems biology” approaches attempt to enhance the predictive value of in vitro biological data by adopting a comprehensive description of biological systems and using computational tools that are sophisticated enough to handle the complexity of these systems. However, the utility of computational models resulting from these eff

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!